BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2148540)

  • 1. Effects of mitogens and lymphokines on the regulation of the immune response to HBs antigen in vitro.
    Knöller I; Hoffmann UJ; Werchau HH; König W
    Immunology; 1990 Nov; 71(3):352-7. PubMed ID: 2148540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro anti-HBs antibody synthesis from anti-hepatitis B vaccine recipients.
    Barnaba V; Levrero M; Ruberti G; van Dyke A; Perrone A; Musca A; Balsano F
    Clin Exp Immunol; 1987 Nov; 70(2):283-8. PubMed ID: 2962789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nature of immunological non-responsiveness to hepatitis B vaccine in healthy individuals.
    Chiou SS; Yamauchi K; Nakanishi T; Obata H
    Immunology; 1988 Jul; 64(3):545-50. PubMed ID: 3261712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of antibody production to hepatitis B surface antigen by interleukin 2.
    Kakumu S; Fuji A; Tahara H; Yoshioka K; Sakamoto N
    J Clin Lab Immunol; 1988 May; 26(1):25-7. PubMed ID: 3263506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoregulation of the in vitro anti-HBs antibody synthesis in chronic HBsAg carriers and in recently boosted anti-hepatitis B vaccine recipients.
    Barnaba V; Valesini G; Levrero M; Zaccari C; Van Dyke A; Falco M; Musca A; Balsano F
    Clin Exp Immunol; 1985 May; 60(2):259-66. PubMed ID: 3874020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro antigen-induced antibody responses to hepatitis B surface antigen in man. Kinetic and cellular requirements.
    Cupps TR; Gerin JL; Purcell RH; Goldsmith PK; Fauci AS
    J Clin Invest; 1984 Oct; 74(4):1204-13. PubMed ID: 6332826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
    Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
    Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of hepatitis B surface antigen-specific immune responses in acute and chronic hepatitis B or after HBs vaccination: stimulation of the in vitro antibody response by interferon gamma.
    Böcher WO; Herzog-Hauff S; Schlaak J; Meyer zum Büschenfeld KH; Löhr HF
    Hepatology; 1999 Jan; 29(1):238-44. PubMed ID: 9862872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of the in vitro anti-HBs response by hepatitis B surface antigen.
    Filion LG; Saginur R
    Clin Exp Immunol; 1988 Dec; 74(3):321-5. PubMed ID: 2976620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of IL-2 and IL-4 on the IgE synthesis and the IgE-binding factor (sCD23) production by human lymphocytes in vitro.
    Knöller I; Bujanowski-Weber J; Brings B; König W
    Immunology; 1989 Mar; 66(3):368-75. PubMed ID: 2522907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low response to HBsAg vaccine in chronic renal failure patients is not due to intrinsic defect of B cells.
    Krishnamurthy G; Kher V; Naik S
    Scand J Urol Nephrol; 2002; 36(5):377-82. PubMed ID: 12487744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The spot-ELISA: a sensitive in vitro method to study the immune response to hepatitis B surface antigen.
    Wismans PJ; van Hattum J; De Gast GC; Endeman HJ; Poel J; Stolk B; Maikoe T; Mudde GC
    Clin Exp Immunol; 1989 Oct; 78(1):75-9. PubMed ID: 2805427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency analysis of HBsAg-specific B lymphocytes in high-responder individuals to recombinant hepatitis B vaccine: comparison of LDA and ELISPOT assays.
    Shokrgozar MA; Sam MR; Amirkhani A; Shokri F
    Scand J Immunol; 2006 Nov; 64(5):536-43. PubMed ID: 17032247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of immune complexes containing HBsAg and HBeAg on IL-2 dependent human lymphocyte proliferation.
    Stachowski J; Michalkiewicz J; Gregorek H; Madalinski K; Maciejewski J
    Allerg Immunol (Leipz); 1990; 36(1):47-60. PubMed ID: 2346099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). V. T cell proliferative response and cellular interactions.
    Milich DR; Louie RE; Chisari FV
    J Immunol; 1985 Jun; 134(6):4194-202. PubMed ID: 3921619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-responsiveness to hepatitis B vaccination in haemodialysis patients: association with impaired TCR/CD3 antigen receptor expression regulating co-stimulatory processes in antigen presentation and recognition.
    Stachowski J; Pollok M; Barth C; Maciejewski J; Baldamus CA
    Nephrol Dial Transplant; 1994; 9(2):144-52. PubMed ID: 7910675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B surface antigen-specific T and B cell memory in individuals who had lost protective antibodies after hepatitis B vaccination.
    Bauer T; Jilg W
    Vaccine; 2006 Jan; 24(5):572-7. PubMed ID: 16171909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). VI. T cell fine specificity.
    Milich DR; Peterson DL; Leroux-Roels GG; Lerner RA; Chisari FV
    J Immunol; 1985 Jun; 134(6):4203-11. PubMed ID: 2580909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of hepatitis B surface antigen (HBsAg) induced interleukin-2 secretion in chronic asymptomatic carriers of HBsAg.
    Sylvan SP; Hekkström UB
    Clin Exp Immunol; 1989 Nov; 78(2):207-13. PubMed ID: 12412750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A five-year observation on efficacy of revaccination in children of non-response to hepatitis B vaccine].
    Zhuang GH; Yan H; Wang XL; Wu Q; Wang LR; Gao HY
    Zhonghua Yu Fang Yi Xue Za Zhi; 2006 Jan; 40(1):8-12. PubMed ID: 16620590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.